We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Transcatheter tricuspid valve replacement using the ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...

SAN FRANCISCO, CA—Patients with severe tricuspid regurgitation (TR) treated with transcatheter valve replacement experienced a significant improvement in TR grade and had “meaningful” improvements in ...

Edwards Lifesciences has secured European approval for its transcatheter tricuspid valve replacement system, which the company described as the first minimally invasive therapy of its kind to receive ...

NEW YORK CITY -- Recent device approvals officially put transcatheter tricuspid valve intervention (TTVI) on the map for symptomatic severe tricuspid regurgitation (TR), though workforce challenges ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first transcatheter tricuspid valve replacement system. The system is indicated for ...

TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, ...

TRiCaresAnnouncesSuccessfulImplantationofMinimallyInvasiveTopazTricuspidHeartValveReplacementSystemin Patient with a Pacemaker Paris, France and Munich, Germany ...

Stopping leaks in the heart’s tricuspid valve has been a notoriously tricky fix, but, now, the FDA is handing out its second approval for a dedicated, minimally invasive therapy in as many months.

The Food and Drug Administration approved a new device from Abbott meant to treat tricuspid heart valve disease — an expected decision after an outside advisory panel voted that the device’s benefits ...

DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR), announced ...

Edwards Lifesciences has received US Food and Drug Administration (FDA) approval for its Evoque tricuspid valve replacement system, which becomes the first transcatheter therapy to be approved in the ...